Commercial lipofection reduced ErbB2 similarly in both tumor lines, whereas HSi reduced ErbB2 only in the HER3+ cells (Figure 7G), demonstrating the specificity of HSi-mediated delivery. Here, ERBB2 is linked to neoplasm.